Burden of Hereditary Transthyretin Amyloidosis on Quality of Life

A Yarlas,Morie A. Gertz,Noel R. Dasgupta,Laura Obici,M. Pollock,Elizabeth J. Ackermann,Andrew Lovley,Asia Sikora Kessler,Pankaj A. Patel,Michelle K. White,Spencer D. Guthrie

Burden of Hereditary Transthyretin Amyloidosis on Quality of Life

2019

A Yarlas
Morie A. Gertz
Noel R. Dasgupta
Laura Obici
M. Pollock
Elizabeth J. Ackermann
Andrew Lovley
Asia Sikora Kessler
Pankaj A. Patel
Michelle K. White
Spencer D. Guthrie

Introduction Hereditary transthyretin (hATTR) amyloidosis is a progressive, degenerative disease, with peripheral neuropathy, cardiomyopathy, and other clinical manifestations. In this study we examine the impact of hATTR amyloidosis on quality of life (QOL).

Keywords:

Anatomy
Amyloidosis
Pediatrics
Quality of life
Diabetes mellitus
Transthyretin
Medicine
Population
Polyneuropathy
Peripheral neuropathy
Internal medicine
Gangrene
Diabetic neuropathy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations